Filing Flows › Fractyl Health (GUTS) › Q4 2024
Fractyl Health (GUTS) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 3, 2025
Fractyl Health (GUTS) reported revenue of $3K for the fourth quarter 2024 (Q4 2024), -57% from a year earlier and -79% from the quarter before.
Fractyl Health, Q4 2024: revenue $3K (-57% year over year), net loss $25.0M, operating cash flow −$17.0M. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3K | -79% | -57% |
| Operating profit | −$25.2M | — | — |
| Net earnings | −$25.0M | — | — |
| Operating cash flow | −$17.0M | — | — |
What changed
Revenue was $3K in Q4 2024, down 57% year over year and down 79% from the previous quarter.
Gross margin was 100.0%, up 28.6 points from a year earlier. Operating costs exceeded revenue by $25.2M, an operating margin of -840333.3%. Operating expenses grew 94% against a revenue fall of 57%. The fastest-growing cost line was Research & development (+99%). The quarter ended with a net loss of $25.0M, wider than the previous quarter's $23.2M loss.
Operating cash flow was −$17.0M. Non-cash charges added back $223K of depreciation and $2.9M of share-based compensation. Working capital and other items added $4.8M. Capital expenditures of $233K exceeded it, leaving free cash flow of −$17.3M.
Questions
What was Fractyl Health's revenue in the fourth quarter 2024?
Fractyl Health (GUTS) reported revenue of $3K for the fourth quarter 2024 (Q4 2024), -57% from a year earlier and -79% from the quarter before.
Source: Fractyl Health 10-K on SEC EDGAR.